PTC Therapeutics Ownership | Who Owns PTC Therapeutics?
PTC Therapeutics Ownership Summary
PTC Therapeutics is owned by 104.37% institutional investors, 2.34% insiders. Vanguard group is the largest institutional shareholder, holding 11.73% of PTCT shares. Vanguard Health Care Inv is the top mutual fund, with 6.26% of its assets in PTC Therapeutics shares.
PTCT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | PTC Therapeutics | 104.37% | 2.34% | -6.71% |
| Sector | Healthcare Stocks | 47.38% | 7.99% | 44.63% |
| Industry | Biotech Stocks | 45.43% | 7.81% | 46.75% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 8.97M | 11.73% | $274.42M |
| Wellington management group llp | 8.21M | 10.73% | $251.02M |
| Blackrock | 7.77M | 10.16% | $237.67M |
| Rtw investments, lp | 7.39M | 9.66% | $226.08M |
| Armistice capital | 6.96M | 9.10% | $212.90M |
| Cowen and company | 3.76M | 4.91% | $114.87M |
| Camber capital management lp | 3.50M | 4.58% | $107.03M |
| Janus henderson group | 2.98M | 3.90% | $91.15M |
| State street | 2.75M | 3.59% | $84.07M |
| Geode capital management | 1.79M | 2.34% | $54.68M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Rtw investments, lp | 7.39M | 3.50% | $226.08M |
| Cowen and company | 3.76M | 3.16% | $114.87M |
| Camber capital management lp | 3.50M | 2.96% | $107.03M |
| Armistice capital | 6.96M | 2.68% | $212.90M |
| Tang capital management | 700.00K | 2.18% | $21.41M |
| Pdt partners | 139.38K | 0.40% | $4.26M |
| Sphera funds management | 94.32K | 0.39% | $2.88M |
| Neo ivy capital management | 40.71K | 0.24% | $1.25M |
| Jacobs levy equity management | 1.72M | 0.22% | $52.47M |
| Vitalstone financial | 9.37K | 0.21% | $286.44K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Goldman sachs group | 791.16K | 0.00% | 311.14K |
| Jefferies financial group | 522.89K | 0.17% | 250.00K |
| Jane street group | 341.83K | 0.00% | 247.14K |
| Nuveen asset management | 686.52K | 0.01% | 219.87K |
| Blackrock | 7.77M | 0.01% | 207.05K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| State street | 2.75M | 0.00% | -1.36M |
| First trust advisors lp | 78.60K | 0.00% | -1.36M |
| Adage capital partners gp | 300.00K | 0.02% | -970.00K |
| Wellington management group llp | 8.21M | 0.04% | -692.96K |
| Janus henderson group | 2.98M | 0.05% | -688.26K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Squarepoint ops | 122.89K | 0.01% | 122.89K | $3.76M |
| Vestal point capital, lp | 90.00K | 0.21% | 90.00K | $2.75M |
| Alps advisors | 59.82K | 0.01% | 59.82K | $1.83M |
| Mirae asset global etfs | 59.70K | 0.00% | 59.70K | $1.84M |
| Campbell & co investment adviser | 57.81K | 0.15% | 57.81K | $1.77M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -14.00 |
| Byrne asset management | -25.00 |
| Federation des caisses desjardins du quebec | -30.00 |
| Innealta capital | -36.00 |
| Newedge advisors | -161.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 204 | 6.81% | 79,836,937 | -6.22% | 104 | 0.84% | 124 | 45.88% | 61 | -11.59% |
| Mar 31, 2024 | 191 | 6.11% | 85,134,817 | 0.70% | 111 | 0.87% | 85 | -13.27% | 69 | 23.21% |
| Dec 31, 2023 | 180 | -3.23% | 84,545,716 | 4.22% | 112 | 0.98% | 98 | -4.85% | 56 | -5.08% |
| Sep 30, 2023 | 186 | -12.26% | 81,125,682 | -0.19% | 107 | 0.91% | 103 | -11.97% | 59 | -6.35% |
| Jun 30, 2023 | 212 | -0.93% | 81,283,028 | 3.74% | 108 | 0.96% | 117 | 9.35% | 63 | -14.86% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 4.81M | 6.26% | 1.42M |
| Vanguard Total Stock Mkt Idx Inv | 2.41M | 3.14% | 2.85K |
| iShares Russell 2000 ETF | 1.96M | 2.55% | -4.41K |
| Vanguard Small Cap Index | 1.92M | 2.50% | -17.91K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.15M | 1.50% | -28.55K |
| SPDR® S&P Biotech ETF | 1.12M | 1.45% | 12.34K |
| Vanguard Small Cap Growth Index Inv | 1.06M | 1.38% | -9.70K |
| Franklin Biotechnology Discv A(acc)USD | 835.03K | 1.09% | - |
| Hartford MidCap Y | 808.97K | 1.05% | -805.13K |
| Fidelity Small Cap Index | 777.79K | 1.01% | -19.56K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 16, 2024 | Gravier Pierre | CHIEF FINANCIAL OFFICER | Sell | $77.20K |
| May 22, 2024 | ZELDIS JEROME B | - | Sell | $764.80K |
| May 07, 2024 | Golden Lee Scott | EVP & CHIEF MEDICAL OFFICER | Sell | $5.74K |
| Apr 19, 2024 | Klein Matthew B. | CHIEF EXECUTIVE OFFICER | Sell | $83.67K |
| Apr 17, 2024 | Pauwels Eric | CHIEF EXECUTIVE OFFICER | Sell | $19.78K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | - | 1 |
| 2024 Q2 | - | 6 |
| 2024 Q1 | - | 22 |
| 2023 Q4 | 1 | - |
| 2023 Q3 | - | 2 |
PTCT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools